Biobot Surgical secured $18M in a Series B funding led by Tony Tan for its Mona Lisa surgical robot.
Biobot Surgical secured $18M in a Series B funding led by Tony Tan for its Mona Lisa surgical robot.
03/07/24, 3:15 PM
Location
singaporeMoney raised
$18 million
Industry
medical
medical device
biotechnology
health care
manufacturing
Round Type
series b
Investors
Zig Ventures, Tony Tan
Biobot Surgical closed a Series B funding round worth $18 million. The round was led by healthcare entrepreneur Tony Tan and saw participation from existing shareholder Zig Ventures. The funds will be used to accelerate the company's global expansion and commercial footprint.
Company Info
Location
singapore, southeast asia, singapore
Additional Info
BIOBOT is a medical technology company dedicated to redefining the standard of care in urology through technological innovation. Its flagship product, the iSR'obot Mona Lisa system, arms urologists with cutting-edge robotic precision and enhanced visualization for percutaneous transperineal procedures.